Robust Metabolomics Data Normalization across Scales and Experimental Designs
Analytical Chemistry · 23.06.2026 · 98 (24) · 17627-17637
DOI: 10.1021/acs.analchem.5c06841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 11.06.2026. Verfasst von Matthijs Vynck und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Integrative Metabolomics (LIMET), Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicin…. Hauptthemen laut MEDLINE: Metabolomics, Research Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Research Council, Fonds Wetenschappelijk Onderzoek, Bijzonder Onderzoeksfonds UGent.
Abstract (Originalsprache)
Metabolomics studies employing liquid chromatography-mass spectrometry are affected by signal drift and batch effects, introducing technical variance that impedes biological knowledge discovery. Quality control (QC) sample-based normalization strategies are widely implemented but remain vulnerable to outliers, thereby reducing normalization performance. We introduce rLOESS, rGAM, and tGAM, three robust normalization methods that improve resistance to outliers by downweighting or accommodating them. Leveraging additive models, the rGAM and tGAM methods allow flexible nonlinear modeling, differential sample weighting, and data-driven QC representativeness evaluation. Implementations of these methods are gathered in the Metanorm R package, integrating robust normalization with visualization for performance verification while supporting efficient parallel processing. In in silico and/or experimental data sets, the robust methods, relative to several popular existing strategies, improved replicate concordance and reduced drift and batch effects. The robust methods, with improved recovery of the underlying signal demonstrated in simulation, produced distinct differential abundance results, highlighting the impact of normalization on downstream statistical inference. Overall, tGAM-based normalization suggested the best performance across scenarios and is proposed as the default choice. Metanorm is versatile, supporting normalization in metabolomics studies across scales and experimental setups. Metanorm is freely available at https://github.com/UGent-LIMET/Metanorm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Integrative Metabolomics (LIMET), Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Salisburylaan 133, Merelbeke 9820, Belgium.
- Environmental and Molecular Epidemiology, Centre of Environmental Sciences, Hasselt University, Martelarenlaan 42, Hasselt 3000, Belgium.
- School of Biological Sciences, Queens' University Belfast, 19 Chlorine Gardens, Belfast BT9 5DL, Northern Ireland.
ORCID-Profile: Matthijs Vynck, Pablo Vangeenderhuysen, Vera Plekhova, Lynn Vanhaecke
Förderung
- European Research Council
- Fonds Wetenschappelijk Onderzoek
- Bijzonder Onderzoeksfonds UGent
- FP7 Ideas: European Research Council
Zitieren
APA
Vynck, M., Vangeenderhuysen, P., De Paepe, E., Nawrot, T., Plekhova, V., & Vanhaecke, L. (2026). Robust Metabolomics Data Normalization across Scales and Experimental Designs. Analytical Chemistry, 98(24), 17627-17637. https://doi.org/10.1021/acs.analchem.5c06841
Vancouver
Vynck M, Vangeenderhuysen P, De Paepe E, Nawrot T, Plekhova V, Vanhaecke L. Robust Metabolomics Data Normalization across Scales and Experimental Designs. Analytical Chemistry. 2026;98(24):17627-17637. doi:10.1021/acs.analchem.5c06841
BibTeX
@article{Vynck2026,
author = {Vynck, Matthijs and Vangeenderhuysen, Pablo and De Paepe, Ellen and Nawrot, Tim and Plekhova, Vera and Vanhaecke, Lynn},
title = {Robust Metabolomics Data Normalization across Scales and Experimental Designs},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {24},
pages = {17627--17637},
doi = {10.1021/acs.analchem.5c06841}
}
EUVIMED